Literature DB >> 23475542

Oxidative stress and the HIV-infected brain proteome.

Lerna Uzasci1, Avindra Nath, Robert Cotter.   

Abstract

Human immunodeficiency virus (HIV) is capable of infiltrating the brain and infecting brain cells. In the years following HIV infection, patients show signs of various levels of neurocognitive problems termed HIV-associated neurocognitive disorders (HAND). Although the introduction of highly active antiretroviral therapy (HAART) has reduced the incidence of HIV-dementia, which is the most severe form of HAND, the milder forms have become more prevalent today due to the increased life expectancy of infected individuals. Pre-HAART era markers such as HIV RNA level, CD4+ count, TNF-α, MCP-1 and M-CSF are not able to clearly distinguish mild from advanced HAND. One promising approach for new biomarker discovery is the identification and quantitation of proteins that are post-translationally modified by oxidative and nitrosative species. The occurrence of oxidative and nitrosative stress in HIV-infected brain, both through the early direct and indirect effects of viral proteins and through the later effect on mitochondrial integrity during apoptosis, is well-established. This review will focus on how the reactive species are produced in the brain after HIV infection, the specific oxidative and nitrosative species that are involved in the post-translational modification of the brain proteome, and the methods that are currently used for the detection of such modified proteins. This review also provides an overview of related research pertaining to oxidative stress-related HAND using cerebrospinal fluid and human brain tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475542      PMCID: PMC3714334          DOI: 10.1007/s11481-013-9444-x

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  120 in total

1.  Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.

Authors:  A Prakash; T Rezai; B Krastins; D Sarracino; M Athanas; P Russo; M M Ross; H Zhang; Y Tian; V Kulasingam; A P Drabovich; C Smith; I Batruch; L Liotta; E Petricoin; E P Diamandis; D W Chan; M F Lopez
Journal:  J Proteome Res       Date:  2010-11-02       Impact factor: 4.466

2.  HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.

Authors:  H C Chang; F Samaniego; B C Nair; L Buonaguro; B Ensoli
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

3.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

4.  Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.

Authors:  F Sabri; E Tresoldi; M Di Stefano; S Polo; M C Monaco; A Verani; J R Fiore; P Lusso; E Major; F Chiodi; G Scarlatti
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

Review 5.  Use of dimedone-based chemical probes for sulfenic acid detection methods to visualize and identify labeled proteins.

Authors:  Kimberly J Nelson; Chananat Klomsiri; Simona G Codreanu; Laura Soito; Daniel C Liebler; Leann C Rogers; Larry W Daniel; Leslie B Poole
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

6.  Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia.

Authors:  Xiaojuan Liu; Malabendu Jana; Subhajit Dasgupta; Sreenivas Koka; Jun He; Charles Wood; Kalipada Pahan
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

7.  Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants.

Authors:  J Turchan; C B Pocernich; C Gairola; A Chauhan; G Schifitto; D A Butterfield; S Buch; O Narayan; A Sinai; J Geiger; J R Berger; H Elford; A Nath
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

8.  Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace.

Authors:  Thomas J Jönsson; Lynnette C Johnson; W Todd Lowther
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

9.  Nitration of tryptophan 372 in succinyl-CoA:3-ketoacid CoA transferase during aging in rat heart mitochondria.

Authors:  Igor Rebrin; Catherine Brégère; Sergey Kamzalov; Timothy K Gallaher; Rajindar S Sohal
Journal:  Biochemistry       Date:  2007-08-08       Impact factor: 3.162

10.  Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.

Authors:  M I Bukrinsky; H S Nottet; H Schmidtmayerova; L Dubrovsky; C R Flanagan; M E Mullins; S A Lipton; H E Gendelman
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  21 in total

1.  Nitrosative Stress Is Associated with Dopaminergic Dysfunction in the HIV-1 Transgenic Rat.

Authors:  Swati Shah; Dragan Maric; Frank Denaro; Wael Ibrahim; Ronald Mason; Ashutosh Kumar; Dima A Hammoud; William Reid
Journal:  Am J Pathol       Date:  2019-07       Impact factor: 4.307

Review 2.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

3.  Mass spectrometric phosphoproteome analysis of HIV-infected brain reveals novel phosphorylation sites and differential phosphorylation patterns.

Authors:  Lerna Uzasci; Sungyoung Auh; Robert J Cotter; Avindra Nath
Journal:  Proteomics Clin Appl       Date:  2015-08-12       Impact factor: 3.494

4.  Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage.

Authors:  Ana B Sanchez; Giuseppe P Varano; Cyrus M de Rozieres; Ricky Maung; Irene C Catalan; Cari C Dowling; Natalia E Sejbuk; Melanie M Hoefer; Marcus Kaul
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

Review 5.  Role of T Lymphocytes in HIV Neuropathogenesis.

Authors:  Caroline Subra; Lydie Trautmann
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

6.  Soluble Insulin Receptor Levels in Plasma, Exosomes, and Urine and Its Association With HIV-Associated Neurocognitive Disorders.

Authors:  Yisel M Cantres-Rosario; Valerie Wojna; Rafael Ruiz; Bexaida Diaz; Miriam Matos; Rosa J Rodriguez-Benitez; Elaine Rodriguez; Richard L Skolasky; Yamil Gerena
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

7.  Biomarkers for NeuroAIDS: recent progress in the field.

Authors:  Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-29       Impact factor: 4.147

8.  Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry.

Authors:  Adriana Bora; Ceereena Ubaida Mohien; Raghothama Chaerkady; Linda Chang; Richard Moxley; Ned Sacktor; Norman Haughey; Justin C McArthur; Robert Cotter; Avindra Nath; David R Graham
Journal:  J Neurovirol       Date:  2014-07-24       Impact factor: 2.643

9.  Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy.

Authors:  Alexander J Gill; Colleen E Kovacsics; Patricia J Vance; Ronald G Collman; Dennis L Kolson
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

Review 10.  Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism.

Authors:  Maria F Chen; Alexander J Gill; Dennis L Kolson
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.